Paving the way towards effective plant-based inhibitors of hyaluronidase and tyrosinase: a critical review on a structure-activity relationship

J Enzyme Inhib Med Chem. 2022 Dec;37(1):1120-1195. doi: 10.1080/14756366.2022.2061966.

Abstract

Human has used plants to treat many civilisation diseases for thousands of years. Examples include reserpine (hypertension therapy), digoxin (myocardial diseases), vinblastine and vincristine (cancers), and opioids (palliative treatment). Plants are a rich source of natural metabolites with multiple biological activities, and the use of modern approaches and tools allowed finally for more effective bioprospecting. The new phytochemicals are hyaluronidase (Hyal) inhibitors, which could serve as anti-cancer drugs, male contraceptives, and an antidote against venoms. In turn, tyrosinase inhibitors can be used in cosmetics/pharmaceuticals as whitening agents and to treat skin pigmentation disorders. However, the activity of these inhibitors is stricte dependent on their structure and the presence of the chemical groups, e.g. carbonyl or hydroxyl. This review aims to provide comprehensive and in-depth evidence related to the anti-tyrosinase and anti-Hyal activity of phytochemicals as well as confirming their efficiency and future perspectives.

Keywords: Hyaluronidase; polyphenols; structure–activity relationship; tyrosinase plant-based inhibitors.

Publication types

  • Review

MeSH terms

  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Hyaluronoglucosaminidase* / metabolism
  • Male
  • Monophenol Monooxygenase*
  • Phytochemicals
  • Plants / chemistry
  • Structure-Activity Relationship

Substances

  • Enzyme Inhibitors
  • Phytochemicals
  • Monophenol Monooxygenase
  • Hyaluronoglucosaminidase

Grants and funding

This work was partially supported by the Nicolaus Copernicus University under the “Excellence Initiative - Research University” programme Emerging Fields (EF)/Sustainable development (SD). Project title: “The Polish–Dutch Platform of plant-based medicines”. And the project “Plant-based adaptogens in the Poland and Germany’s pharmaceutical practice from the Medieval to the Contemporary” within the Polish Historical Mission at the University of Julius Maximilian in Würzburg, Germany.